$AREB

AMERICAN REBEL HOLDINGS INC (AREB): Entry into a Material Definitive Agreement

AMERICAN REBEL HOLDINGS INC (AREB) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 E xhibit 10.1 SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT (this “ Agreement ”), dated as of June 9, 2026 (the “ Execution Date ”), is entered into by and between AMERICAN REBEL HOLDINGS, INC. , a Nevada corporation (the “ Company

Original reporting
Published Jun 18, 2026, 5:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 18, 2026, 5:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$AREB
Neutral
medium confidence
Mentioned
$AREB
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AREBNeutralMed
01

Why it matters

A funded convertible promissory note introduces potential dilution upon conversion and may affect liquidity/financing expectations for AREB. Traders will likely focus on conversion mechanics and any near-term funding runway implications once the full exhibits are reviewed.

02

Market read

Convertible note financing is a concrete, tradable catalyst because it can change dilution expectations and near-term supply/demand for the stock.

03

What to watch

The excerpt does not include the note’s conversion price/discount, share cap, maturity, interest rate, or any registration/lock-up provisions—those details drive actual dilution and trading impact.

Relevance 6/10Novelty 7/10Timing: Filed June 18, 2026 (after-hours/late session) as an 8-K convertible note financing disclosure.

Background

The 8-K reports entry into a material definitive agreement and includes a securities purchase agreement dated June 9, 2026, with Quick Capital, LLC.

Company-level read

Ticker impact

$AREBNeutralMedium confidence
Context

American Rebel Holdings entered a securities purchase agreement for a $132,000 funded convertible promissory note convertible into common shares.

Expected impact

Likely short-term negative-to-neutral bias from dilution/convertible overhang; magnitude depends on conversion terms not shown in the excerpt.

Evidence & confidence

8-K Item 1.01/2.03/3.02 plus an exhibit describing a convertible note issuance is a primary financing disclosure, but the excerpt omits key conversion mechanics (conversion price, discount, maturity, caps), limiting precision.

Market effects

Adds to the broader microcap/small-cap pattern of convertible financings, which can pressure peer sentiment around dilution risk.

No clear regional spillover indicated beyond US microcap capital markets.

No direct global linkage in the provided text.

Counterpoint

If the note’s conversion terms are favorable (e.g., high conversion price, limited shares, or investor protections), the dilution overhang could be smaller than typical convertibles.

Key entities

  • AMERICAN REBEL HOLDINGS, INC.

    Subject of the 8-K; issues the convertible promissory note and reserved conversion shares.

  • QUICK CAPITAL, LLC

    Counterparty purchasing the convertible note under the securities purchase agreement.

Related articles

$CEROHighAI 8/10

Delisting of Securities from The Nasdaq Stock Market

Nasdaq said it will delist multiple issuers’ securities from the Nasdaq Stock Market, including CERo Therapeutics Holdings, Bowen Acquisition Corp, Graphjet Technology, Blue Hat Interactive Entertainment Technology, X3 Holdings Co, Captivision Inc, Actelis Networks, American Rebel Holdings, Reviva Pharmaceuticals, Alchemy Investments Acquisition Corp 1, Bitcoin Depot, Inotiv, GoHealth, Functional Brands, Sleep Number, Smart Digital Group, and REE Automotive. Most were suspended in 2025-2026 and

$CRWVHighAI 9/10

CRWV Stock Drops to $80 on Soaring Costs as CoreWeave Plans $3 Billion Convertible Debt Offering

CoreWeave (CRWV) shares dropped nearly 5% to below $80 after announcing a $3 billion convertible debt offering and a potential $2.92 billion equity raise to fund infrastructure expansion. The company aims to use proceeds for growth and to offset shareholder dilution, but the financing plans highlight its capital-intensive expansion and dependence on external funding.

$GEHighAI 8/10

GE Looks 15.6% Overvalued on GF Value™ as Boeing 777X Engine Upd

GE Aerospace's CFO addressed durability concerns about the GE9X engine, assuring no delay for Boeing's 777X. The company redesigned the component and began shipping updated engines. GE's stock is trading at $313.47, 15.6% above its GF Value™ of $271.20, indicating modest overvaluation. The company's GF Score™ is 76/100, with strong momentum but mixed insider and guru activity.

$CACCMedAI 8/10

Credit Acceptance settlement provides $700 million in debt relief, restitution and penalties

Credit Acceptance Corp. agreed to a $700M settlement, including $630M in debt relief, $60M in restitution, and $15.5M in penalties. The deal, led by New York AG Letitia James and 39 other states, covers 55,000 borrowers. The company must change its default handling and add-on product sales practices. The settlement resolves allegations of predatory lending and misrepresentation of loan terms.

$JPMMedAI 8/10

JPMorgan Chase (JPM) Commits $750 Billion to Rebuilding America’s Housing Supply

JPMorgan Chase (JPM) plans to invest $750 billion by 2035 to boost U.S. housing supply, including financing 1 million affordable units and aiding 500,000 homebuyers. The bank reported record Q2 net income of $21.2 billion, supporting its expanded housing efforts. Potential benefits include increased mortgage revenue and customer relationships, but risks include credit exposure and market conditions.

$AXONMedAI 8/10

Axon Rebounded 6% Wednesday. Here’s What Could Drive the Stock Through 2026

Axon Enterprise's stock rebounded 6% to $468 on Wednesday after a 10% drop following a $1 billion convertible notes offering. The company expects 32-34% revenue growth in 2026, with strong Q4 growth anticipated. Analysts maintain bullish targets, citing Axon's faster expansion compared to competitors like Motorola Solutions. The stock has an implied upside of 56% based on a valuation model target of $706.